DLinDMA

CAS No. 871258-12-7

DLinDMA( —— )

Catalog No. M24885 CAS No. 871258-12-7

DLinDMA, as a benchmark, is a key stable nucleic acid lipid particleslipid component.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 53 In Stock
50MG 77 In Stock
100MG 114 In Stock
200MG 172 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DLinDMA
  • Note
    Research use only, not for human use.
  • Brief Description
    DLinDMA, as a benchmark, is a key stable nucleic acid lipid particleslipid component.
  • Description
    DLinDMA, as a benchmark, is a key stable nucleic acid lipid particleslipid component.
  • In Vitro
    The structure of DLinDMA can be divided into three main regions: the hydrocarbon chains, the linker and the headgroup.
  • In Vivo
    DLinDMA has virtually indistinguishable blood pharmacokinetic profiles in mice.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    871258-12-7
  • Formula Weight
    616.06
  • Molecular Formula
    C41H77NO2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 100 mg/mL (162.32 mM);DMSO: < 1 mg/mL (insoluble or slightly soluble)
  • SMILES
    CCCCC/C=C\C/C=C\CCCCCCCCOCC(OCCCCCCCC/C=C\C/C=C\CCCCC)CN(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Semple SC, et al. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol. 2010 Feb;28(2):172-6.
molnova catalog
related products
  • Ilexoside XLVIII

    Ilexoside XLVIII is an acyl CoA cholesteryl acyl transferase ( ACAT ) inhibitor. Ilexoside XLVIII is a triterpene saponin isolated from an aqueous extract of the leaves of Ilex kudincha.

  • Formononetin

    Formononetin is a phytoestrogen from the root of Astragalus membranaceus and an O-methylated isoflavone.

  • ACT-389949

    ACT-389949 is a potent and selective agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes.